º£½ÇÉçÇø

Wei Li Lab

Wei Li Lab Publications

Master
Heading

Selected Publications

Content

Tang, F., LeBlanc, M.E., Wang, W., Liang, D., Chen, P., Chou, T., Tian, H., Li, W. (2019) Anti-Secretogranin III Therapy of Oxygen-Induced Retinopathy with Optimal Safety. Angiogenesis. 22(3): 369-382.

LeBlanc, M.E., Wang, W., Ji, Y., Tian, H., Liu, D., Zhang, X., Li, W. (2019) Secretogranin III as a novel target for the therapy of choroidal neovascularization. Exp. Eye Res. 181:120-126.

Rong, X., Tian, H., Yang, L., Li, W. (2019) Function-first ligandomics for ocular vascular research and drug target discovery. Exp. Eye Res. 182: 57-64.

Li, W., Pang, I.H., Pacheco, M.T.F., Tian, H. (2018) Ligandomics: A paradigm shift in biological drug discovery. Drug. Discov. Today. 23(3):636-643.

Li, W., Webster, K.A., LeBlanc, M.E., Tian, H. (2018) Secretogranin III: A diabetic retinopathy-selective angiogenic factor. Cell. Mol. Life. Sci. 75(4):635-647.

LeBlanc, M.E., Wang, W., Chen, X., Caberoy, N.B., Guo, F., Chen, X., Ji, Y., Tian, H., Wang, H., Chen, R., Li W. (2017) Secretogranin III as a disease-associated ligand for anti-angiogenic therapy of diabetic retinopathy. J. Exp. Med. 214(4):1029-1047.

Wang, W., LeBlanc, M.E., Chen, X., Chen, P., Ji, Y., Brewer, M., Tian, H., Spring, S.R., Webster, K.A., Li, W. (2017) Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease. Angiogenesis. 20(4):479-492.

LeBlanc, M.E., Wang, W., Caberoy, N.B., Chen, X., Guo, F., Alvarado, G., Shen, C., Wang, F., Wang, H., Chen, R., Liu, Z., Webster, K., Li, W. (2015) Hepatoma-derived growth factor-related protein-3 is a novel angiogenic factor. PloS One 10(5):e0127904.

Li, W (2012) ORF phage display to identify cellular proteins with different functions. Methods 58(1): 2-9.

Li, W and Caberoy, N.B. (2010) New perspective for phage display as an efficient and versatile technology of functional proteomics. Appl. Microbiol. Biotechnol. 85(4): 909-919.

Caberoy, N.B. Zhou, Y., and Li, W. (2010) Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis. EMBO J. 29(23): 3898-3910.

Caberoy, N.B., Zhou, Y., Jiang, X., Alvarado, G., and Li, W. (2010) Efficient identification of tubby-binding proteins by an improved system of T7 phage display. J. Mol Recognit. 23(1):74-83.